Project Grant HT94252510326
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$621K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
The Johns Hopkins University was awarded an $818,750 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from September 2022 through September 2025 to reprogram the immune landscape of osteosarcoma by utilizing STING and lymphotoxin receptor agonists. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The U.S. Department of the Army Medical Command awarded a $2,382,063 Project Grant to The Johns Hopkins University under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "NERVE TO HEAL: OPTIMIZATION OF TENDON HEALTH USING NERVE-SPECIFIC SMALL MOLECULES," supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research aims to investigate innovative approaches to...
The Johns Hopkins University has been awarded a $1,099,238 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a period of performance from September 1, 2024 to August 31, 2026. This grant will support investigator-initiated biomedical research projects across multiple medical disciplines to improve health outcomes for military service members, veterans, and the broader public. The award enables Johns Hopkins to conduct...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $855,728 to The Johns Hopkins University to identify abnormally regulated lipid pathways in human motor neuron and fly models, with the goal of developing a new pharmacological drug candidate. The award period runs from Sep 1, 2024 to Aug 31, 2026. As a leading research university, Johns Hopkins has a strong track record of federal grant...
The Johns Hopkins University received a $248,356 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiometabolic Comorbidity and Outcomes in Multiple Sclerosis: A Polygenic Risk Score Approach". The award period runs from September 1, 2023 to August 31, 2025. The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research....
The Johns Hopkins University was awarded a $974,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, spanning August 1, 2023 to July 31, 2026, will support research to engineer an effective combination therapy of car T cells and regulatory T cells to control rejection of vascularized composite allografts. This research aims to develop medical solutions for the battlefield and transform healthcare for...
This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
The Department of the Army Medical Command awarded a $319,938 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Johns Hopkins University. The grant, with a performance period from September 1, 2024 to August 31, 2026, will fund a large-scale MRI-based study to determine multiple sclerosis-specific atrophy phenotypes. This research aims to transform healthcare for military service members and the broader public by advancing the understanding and...
The Johns Hopkins University was awarded a $1,545,272 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to transform radiation therapy and preserve neurocognition in children with brain tumors. The 4-year award, which began on July 1, 2023, will fund research to develop innovative approaches that minimize the negative impact of radiation treatment on cognitive function in pediatric patients. The grant supports biomedical...